This study is looking at how a medicine called ALTO-101T works for people with schizophrenia, a condition affecting the brain and thoughts. The study will use a test called an electroencephalogram (EEG) to see how the brain works while taking the medicine. Participants will wear a patch on their skin that delivers the medicine, known as a transdermal delivery system (TDS). The study also checks how safe the medicine is and how the body breaks it down, called pharmacokinetics (PK).

• The study involves multiple visits, and participants must follow all the procedures.
• Participants should already be on stable doses of 1-2 schizophrenia medicines.
• People with certain conditions like major depression or substance use disorders can't join.